Latest Iron News

Alterity Therapeutics has reported positive Phase 2 results for ATH434, showing significant slowing of Multiple System Atrophy progression and a favorable safety profile. The trial demonstrated clinical benefits alongside reductions in brain iron accumulation, a key disease driver.

Firebird Metals Limited has secured preliminary design approval for its battery-grade manganese sulphate plant in China and forged a strategic partnership to develop LMFP cathode materials, marking significant progress in its EV battery ambitions.

Carbine Resources reports steady progress on its Muchea West silica sand mining licence application, engaging environmental consultants to support upcoming approvals. The company also continues exploration efforts at its Down South project.

Coppermoly Limited has advanced its Mt Isa exploration program with fresh geophysical surveys and strategic board appointments, aiming to unlock new copper and gold targets in Queensland.

Centaurus Metals reports significant progress in its Jaguar Nickel Sulphide Project, delivering a high-grade nickel concentrate and advancing mine optimisation, while also making strides in copper and iron ore projects in Brazil.

Sky Metals has reported strong progress at its Tallebung tin project, completing surface trenching and initiating bulk sampling to validate resource estimates and optimise metallurgical processes. A recent $6 million capital raise will fund expanded drilling and development studies, positioning the company for near-term growth.

Carawine Resources releases an amended December 2024 quarterly report highlighting exploration progress in the Paterson province and ongoing legal proceedings over a compulsory acquisition by major shareholder QGold.

Castile Resources has validated a cutting-edge seismic method to pinpoint ironstone orebodies, setting the stage for a major drilling campaign and a robust Bankable Feasibility Study backed by a $4.1 million capital raise.

Champion Iron reported solid Q3 FY2025 results despite a two-week shipment interruption, while progressing its DRPF upgrade and forging a key partnership for the Kami Project.

Nickel Industries delivered a record US$72.4 million EBITDA in Q4 2024, driven by strong operational milestones and strategic project advancements. However, currency fluctuations posed a significant challenge, underscoring the company’s exposure to foreign exchange risks.

Alterity Therapeutics has announced encouraging Phase 2 trial results for ATH434, showing significant slowing of disease progression in multiple system atrophy (MSA) patients and a strong safety profile. These findings mark a potential breakthrough in treating a disease with no approved therapies.

Champion Iron Limited reported robust financial results for the nine months ended December 31, 2024, alongside a strategic partnership to develop its Kami Project with Nippon Steel and Sojitz.